Physician profile
Michael John Marcinczyk
NPI 1841261245
$9,722.14
in general payments reported to CMS, 2019-2025
11 companies · $25.20 in 2025
The $25.20 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,348 · 2020: $705 · 2021: $163 · 2023: $444 · 2024: $37.32 · 2025: $25.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $7,721.64 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $499.49 | 2019-2020 | |
| Medtronic, INC. | $444.23 | 2023 | Endurant Iis, Valiant Captivia, Ellipsys Vascular Access System |
| W. L. Gore & Associates, INC. | $373.22 | 2019 | |
| Abbott Laboratories | $219.91 | 2019-2020 | |
| Silk Road Medical, INC. | $162.50 | 2021 | |
| Cardinal Health 200 LLC | $111.37 | 2020 | |
| Boston Scientific Corporation | $90.98 | 2020 | |
| Cormedix INC. | $37.32 | 2024 | Defencath |
| Cardiovascular Systems INC. | $36.28 | 2020 | |
| Becton, Dickinson and Company | $25.20 | 2025 | Covera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Marcinczyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.